Analystreport

Charles River Laboratories Intl. Inc (NYSE: CRL) had its price target raised by analysts at UBS Group AG from $200.00 to $236.00. They now have a "buy" rating on the stock.

Charles River Laboratories International, Inc.  (CRL) 
Last charles river laboratories international, inc. earnings: 2/11 07:00 am Check Earnings Report
US:NYSE Investor Relations: ir.criver.com